在COPD中新兴的治疗方法:将创新映射到可治疗的特征
Mario Cazzola1, Vanessa M McDonald2,3, Daiana Stolz4
1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy. mario.cazzola@uniroma2.it.
Lung
|September 3, 2025
概括
可治疗特征 (TTs) 方法通过针对特定患者特征的新疗法来个性化慢性阻塞性肺病 (COPD) 管理. 这一精准医疗策略旨在通过超越一刀切的治疗方法来改善COPD患者的治疗结果.
科学领域:
- 肺部医学
- 药理学
- 精准医学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种具有多种表型和病理生物学的异质疾病.
- 目前的管理策略往往由于"一刀切"的性质而失败,限制了解决患者异质性的有效性.
研究的目的:
- 探索可治疗特征 (TTs) 框架与新兴的COPD药物疗法之间的协同作用.
- 将新型抗炎药物和支气管扩展剂与COPD患者的特定可修改的TT进行映射.
主要方法:
- 在TT框架中审查和分析新兴的药物疗法.
- 将药物类别 (例如,抗炎药物,支气管扩展剂) 映射到相关的TT (例如,乙酸性炎症,慢性支气管炎,恶化).
- 强调生物标志物驱动的表型和基于TT的临床试验设计的现实数据.
主要成果:
- 新兴疗法,特别是抗炎药物和支气管扩展剂,可以与特定的TT结合.
- 生物标志物驱动的表型化对于有效的基于TT的试验设计至关重要.
- 挑战包括特征不稳定性,并发症聚类和试验设计异质性.
结论:
- 整合新兴疗法与TT方法为个性化COPD治疗提供了一个有前途的途径.
- 这种精准医疗模式可以改善患者的治疗效果,
- 整合数字健康,长期跟进和成本效益对于转化相关性至关重要.
相关概念视频
COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K


